MediciNova, Inc. (MNOV) Reaches $13.48 After 5.00% Down Move; Idexx Laboratories (IDXX) Has 0.81 Sentiment

March 14, 2018 - By Linda Rogers

The stock of MediciNova, Inc. (NASDAQ:MNOV) is a huge mover today! The stock decreased 3.09% or $0.43 during the last trading session, reaching $13.48. About 186,201 shares traded. MediciNova, Inc. (NASDAQ:MNOV) has declined 6.61% since March 14, 2017 and is downtrending. It has underperformed by 23.31% the S&P500.The move comes after 9 months negative chart setup for the $551.72 million company. It was reported on Mar, 14 by We have $12.81 PT which if reached, will make NASDAQ:MNOV worth $27.59M less.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $17.73 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 69.21 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

The stock decreased 0.51% or $1.04 during the last trading session, reaching $203.49. About 283,789 shares traded. IDEXX Laboratories, Inc. (IDXX) has risen 83.30% since March 14, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on April, 27. They expect $0.93 earnings per share, up 43.08% or $0.28 from last year’s $0.65 per share. IDXX’s profit will be $81.03 million for 54.70 P/E if the $0.93 EPS becomes a reality. After $0.77 actual earnings per share reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts 20.78% EPS growth.

Fundsmith Llp holds 15.34% of its portfolio in IDEXX Laboratories, Inc. for 18.49 million shares. Capital Counsel Llc Ny owns 733,063 shares or 10.2% of their US portfolio. Moreover, American Capital Management Inc has 5% invested in the company for 515,893 shares. The New York-based Tirschwell & Loewy Inc has invested 3.64% in the stock. Bamco Inc Ny, a New York-based fund reported 4.73 million shares.

Since January 1, 0001, it had 2 buys, and 6 insider sales for $21.47 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: